REGENCERX Trademark

Trademark Overview

On Tuesday, June 25, 2013, a trademark application was filed for REGENCERX with the United States Patent and Trademark Office. The USPTO has given the REGENCERX trademark a serial number of 85969858. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, December 24, 2021. This trademark is owned by Cambia Health Solutions, Inc.. The REGENCERX trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business consulting for the health care and pharmaceutical industries
regencerx

General Information

Serial Number85969858
Word MarkREGENCERX
Filing DateTuesday, June 25, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, December 24, 2021
Registration Number4818385
Registration DateTuesday, September 22, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 3, 2014

Trademark Statements

Goods and ServicesBusiness consulting for the health care and pharmaceutical industries

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, July 8, 2013
Primary Code035
First Use Anywhere DateSunday, September 1, 2013
First Use In Commerce DateSunday, September 1, 2013

Trademark Owner History

Party NameCambia Health Solutions, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPortland, OR 97201
Party NameCambia Health Solutions, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPortland, OR 97201
Party NameCambia Health Solutions, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPortland, OR 97201

Trademark Events

Event DateEvent Description
Friday, October 4, 2013NON-FINAL ACTION MAILED
Friday, June 28, 2013NEW APPLICATION ENTERED
Monday, July 8, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 3, 2013ASSIGNED TO EXAMINER
Thursday, October 3, 2013NON-FINAL ACTION WRITTEN
Tuesday, April 1, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 28, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, April 1, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 2, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 3, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 25, 2014ASSIGNED TO LIE
Friday, April 25, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 14, 2014NOTICE OF PUBLICATION
Tuesday, June 3, 2014PUBLISHED FOR OPPOSITION
Tuesday, July 29, 2014NOA MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 28, 2015SOU EXTENSION 1 FILED
Wednesday, January 28, 2015SOU EXTENSION 1 GRANTED
Wednesday, July 29, 2015TEAS STATEMENT OF USE RECEIVED
Wednesday, July 29, 2015USE AMENDMENT FILED
Friday, August 14, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 14, 2015STATEMENT OF USE PROCESSING COMPLETE
Saturday, August 15, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Tuesday, September 22, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, September 22, 2021TEAS SECTION 8 & 15 RECEIVED
Friday, January 30, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Friday, August 14, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, December 22, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, December 24, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, December 24, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, September 22, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

regencerx pharmaceutical industries care health consulting business